Oral semaglutide launches in the UK
A tablet form of semaglutide, branded Wegovy, went on sale in the UK on 6 July, the first GLP-1 medicine available as a pill rather than an injection. The MHRA approved it a month earlier. A National Pharmacy Association survey published on launch day reported that around three-quarters of pharmacies expected to start significant numbers of eligible patients on it.
What this is. A dated, sourced note on something that changed. Peptide Register is an independent reference: it sells nothing, carries no advertising, and takes no money from any company selling any compound it covers. This is not medical advice. If a change affects a medicine you are prescribed, speak to your doctor or pharmacist rather than acting on something you read here.